No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Haemonetics Reports Balanced Earnings With Growth and Challenges
Express News | Trump: An executive order will be signed, and pharmaceutical prices will immediately decrease by 30% to 80%.
Haemonetics Corporation Just Beat EPS By 8.7%: Here's What Analysts Think Will Happen Next
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $95
Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Cuts Target Price to $105
Here's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings